Developing new treatments for childhood leukemia
Official title: Clinical Trials Specialist in Developmental Therapeutics
Funded at Columbia University Health Sciences · NIH-10920409 · Data updated 2026-11-12
This study is all about finding better treatments for kids with leukemia by trying new ways to give medicine and making sure more children, especially from different backgrounds, can join in on these important trials, while also helping train future doctors in this field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 5, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $175,944 |
| NIH project number | 5R50CA278916-02 |
| Project ID | NIH-10920409 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are children aged 0-11 years diagnosed with leukemia or related myeloid diseases.
✕Less likely to help
Patients with leukemia who are older than 21 years or those with conditions not related to myeloid diseases may not benefit from this research.
What this research studies
This research focuses on enhancing treatment options for childhood leukemia by leading a team dedicated to developing and expanding clinical trials. The team will work on innovative methods, such as dose de-escalation of specific medications, to improve outcomes for young patients. Additionally, efforts will be made to increase participation in these trials, particularly among minority populations, ensuring that more children have access to potentially life-saving therapies. The project also emphasizes mentoring the next generation of researchers in pediatric oncology.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored treatments for children with leukemia, improving their chances of remission and overall survival.
How similar studies have gone: Previous research in pediatric oncology has shown success in developing innovative treatment approaches, indicating a promising potential for this project.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Hijiya, Nobuko — Columbia University Health Sciences
- Study coordinator: Hijiya, Nobuko
Related research
Other NIH-funded projects on the same topics.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
HPV-based cervical cancer screening and treatment implementation in resource-limited settings
A collaborative project to help doctors in South Africa put HPV-based screening and same-day treatment for cervical cancer into routine care, so more people get fast, effective care.
-
Cervical cancer screening and treatment rollout in resource-poor settings
A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.
-
Understanding SCN3A-related Developmental Epileptic Encephalopathy and Finding Better Treatments
This NIH grant focuses on how SCN3A gene variants cause developmental epileptic encephalopathy and aims to develop more effective therapies for affected patients.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.